Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ATP7A inhibitors(ATPase copper transporting alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization 4e Therapeutics, Inc.Startup |
Active Organization 4e Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Discovery | US | 4e Therapeutics, Inc.Startup | 30 Nov 2022 |